Research Radartracking 0 published studies · 2 cancer pages · updated Jun 2026Open the Research Map →

Essiac Tea

Essiac (burdock/sheep sorrel/elm/rhubarb blend) scavenges ROS for antioxidant protection, aids detox/liver/immune via NF-κB ↓, with anecdotal anti-inflammatory signals. Limited evidence in breast/prostate/general; safe short-term but monitor GI/diuretics—adjunct at 30–90 ml/day.

← All agents

Human-reviewed · How we review →

AI extractedhuman reviewedsources checkedretractions suppressed

👥⭐ Anecdotal — Mostly anecdotal data. Limited preclinical data and user reports; no strong clinical evidence for anti-cancer effects.EssiacFlor EssenceOjibwa Tea

Forms: Herbal tea infusion (OTC, 1–2 oz daily)

Educational only, not medical advice. OncoForge makes no claim that Essiac Tea treats, prevents, or cures any condition, beyond what the linked studies show. Evidence levels vary; effects may not translate to people, and some compounds can cause harm. Always coordinate with your oncology team.

Key Takeaway

A traditional herbal blend that may help reduce cancer-promoting inflammation and support liver and immune health, with some user-reported benefits.

Evidence at a glance

Tier 1 · labBreastProstateGeneral supportive

Anecdotal/preclinical limited; no RCTs—user reports and lab signals only.

How it may work

Essiac Tea, a blend of burdock root, sheep sorrel, slippery elm, and Indian rhubarb root, exhibits antioxidant properties by scavenging reactive oxygen species (ROS), protecting DNA from damage. It may suppress NF-κB signaling through its herbal components, reducing inflammation-driven tumor growth. The herbs support detoxification via liver and immune modulation, potentially enhancing immune surveillance. Anecdotal and preclinical evidence suggests anti-inflammatory and detox effects, but mechanisms in cancer are not well-elucidated.

Targets & pathways

Curated mechanistic targets reported for this agent — how it may act on cells, not proof of a clinical effect.

  • DetoxificationSupports liver/immune modulation; carcinogen clearance
  • ROSScavenges free radicals; DNA protection
  • NF-κBReduces inflammation-driven tumor growth
  • Immune SurveillancePotential enhancement via herbal modulation
DetoxROS

Often studied / combined with

Combinations reported in the literature, not a protocol or a recommendation.

Overlapping mechanisms

Safety & interactions

Severity and how well-established each signal is are shown separately. Verify everything with your oncologist or pharmacist — absence here does not mean safe.

Risk categories
Gi Upset MildDiuretic InteractionPregnancy CautionAllergy Risk
Potential interactions
  • Diuretics (e.g., furosemide)MonitorModerateTheoreticalAdditive electrolyte loss from rhubarb.
  • ROS-dependent chemo/radiationTime SeparateModerateTheoreticalAntioxidant may blunt oxidative therapy effects.
  • Curcumin / EGCG / Milk ThistleConsiderBeneficialTheoreticalAnti-inflammatory/ROS/detox synergies in breast/general care.

Timing

References

Research

No published studies for Essiac Tea yet

New studies appear here once they’ve been reviewed. Browse all studies.

Dose: as studied, not a recommendation

These are doses as studied or reported, never a recommendation. The right amount of Essiac Tea depends on you, your other medicines, and your situation; decide it with your oncology team and pharmacist, not from a web page.

Ranges seen in adjunct / practice use: 30–90 ml (po) Traditional: 1 oz (30 ml) 1–3x/day on empty stomach, diluted in warm water. Modern protocols: 1–3 oz/day; no HED from animals due to anecdotal origins—start low (1 oz/day) and titrate based on tolerance., Brewed from bulk herbs or pre-mixed (e.g., 4-herb formula). Refrigerate concentrate; shake before use. Quality varies—source from reputable suppliers. Not for long-term high doses without guidance; monitor for GI effects..

Trials studying Essiac Tea

No actively-recruiting trials matched right now. Recruiting is not the same as proven. Search ClinicalTrials.gov →

Inclusion here is not an endorsement. OncoForge makes no claim beyond what the linked studies show. Discuss anything on this page with your oncology team before acting on it.

← All agents · Research Radar